Aptus Pharma Complete Financial Statements

In FYNone, Aptus Pharma (APPL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 10.6% and ROE of 21.7%. Full financial statements from FY2023 to FY2026 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Aptus Pharma share price today.

4 Years of Data
2026 - 2023

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 10.64% 2026 data
EBITDA Margin 14.89% 2026 data
Operating Margin 16.00% 2026 data
Return on Assets 11.36% 2026 data
Return on Equity 21.74% 2026 data

Balance Sheet Ratios

Current Ratio 35.00 2026 data
Equity Ratio 52.27% 2026 data
Asset Turnover 1.07 2026 data

APPL Revenue, Net Profit & EBITDA — Year-on-Year Growth

APPL YoY (March 2026 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+100.0%
Year-over-Year
Equity Growth
+228.6%
Year-over-Year
Financing Cash Flow Growth
+133.3%
Year-over-Year

APPL Income Statement — Revenue, EBITDA & Net Profit

Aptus Pharma revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 10.6%. Explore APPL true value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023
Revenue 0 47 25 18 14
Expenses 0 39 20 16 13
EBITDA 0 7 5 2 1
Operating Profit Margin % 0.00% 16.00% 20.00% 9.00% 4.00%
Depreciation 0 0 0 0 0
Interest 0 1 1 0 0
Profit Before Tax 0 6 4 1 0
Tax 0 2 1 0 0
Net Profit 0 5 3 1 0
Earnings Per Share (₹) 0.00 7.78 6.37 5.32 1.30

APPL Balance Sheet — Assets, Liabilities & Shareholders' Equity

APPL total assets ₹44 Cr, total equity ₹23 Cr, total liabilities ₹ Cr (2026) — ROE 21.7%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023
ASSETS
Total Assets 44 22 10 6
Current Assets 35 20 8 6
Fixed Assets 3 1 1 1
Capital Work in Progress 0 0 0 0
Investments 14 0 0 0
Other Assets 0 21 9 6
LIABILITIES
Total Liabilities
Current Liabilities 1 3 4 2
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 23 7 2 1
Share Capital 7 5 0 0
Reserves & Surplus 17 2 2 1

APPL Cash Flow Statement — Operating, Investing & Financing

Aptus Pharma operating cash flow ₹-2 Cr, investing ₹-1 Cr, financing ₹7 Cr, net cash flow ₹4 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023
Operating Activities -2 -2 0
Investing Activities -1 0 0
Financing Activities 7 3 1
Net Cash Flow 4 0 0